Exploring The Medical Burden of Thyroid Tumour Patients Under the Reform of Critical Illness Insurance in China: In the Patient's Subjective Perspective
DOI:
https://doi.org/10.54691/bcpbm.v24i.1515Keywords:
Critical illness insurance reform; thyroid tumours; medical burden; patient subjective perception.Abstract
In late October 2020, the final proposal of the New Definition of Critical Illness Insurance passed the review of the CBRC and thyroid cancer - a cancer with a high incidence rate - became a graded benefit according to its severity. Taking the clinical treatment of thyroid tumours as an example, this paper explores patients' subjective perceptions of the post-reform medical burden through questionnaires and field interviews in collaboration with the Department of Thyroid Surgery of West China Hospital of Sichuan University and using sample data from across China. Based on the impact of the critical illness insurance reform, suggestions are made for optimising the path of reform promotion and building a new pattern of shared medical care among patients, insurance companies and the government.
Downloads
References
Zafar S Y, Peppercorn J M, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out‐of‐pocket expenses and the insured cancer patient's experience [J]. The oncologist, 2013, 18 (4): 381-390.Fangfang. Research on power load forecasting based on Improved BP neural network [D]. Harbin Institute of Technology, 2011.
Kankeu H T, Saksena P, Xu K, et al. The financial burden from non-communicable diseases in low-and middle-income countries: a literature review [J]. Health research policy and systems, 2013, 11 (1): 1-12.
Li Y, Wu Q, Xu L, et al. Factors affecting catastrophic health expenditure and impoverishment from medical expenses in China: policy implications of universal health insurance [J]. Bulletin of the World Health Organization, 2012, 90: 664-671.
Downloads
Published
Issue
Section
